7n43

Publication Abstract from PubMed

OmIA, isolated from Conus omaria venom, is a potent antagonist at alpha7 nAChRs. We determined the co-crystal structure of OmIA with Lymnae stagnalis acetylcholine binding protein (Ls-AChBP) that identified His5, Val10 and Asn11 as key determinants for the high potency of OmIA at alpha7 nAChRs. Remarkably, despite a competitive binding mode observed in the co-crystal structure, OmIA and analogues displayed functional insurmountable antagonism at alpha7 and alpha3beta4 nAChRs, except OmIA analogues having long side chain at position 10 ([V10Q]OmIA and [V10L]OmIA), which were partial insurmountable antagonist at alpha7 nAChRs in the presence of type II positive allosteric modulators (PAMs). A "two-state, two-step" model was used to explain these observations, with [V10Q]OmIA and [V10L]OmIA co-existing in a fast reversible/surmountable as well as a tight binding/insurmountable state. OmIA and analogues also showed biphasic-inhibition at alpha7 nAChRs in the presence of PNU120596, with a preference for the high-affinity binding site following prolonged exposure. The molecular basis of binding and complex pharmacological profile of OmIA at alpha7 nAChRs presented in here expands on the potential of alpha-conotoxins to probe the pharmacological properties of nAChRs and may help guide the development novel alpha7 modulators.

Unique Pharmacological Properties of alpha-Conotoxin OmIA at alpha7 nAChRs.,Ho TNT, Abraham N, Lewis RJ Front Pharmacol. 2021 Dec 8;12:803397. doi: 10.3389/fphar.2021.803397. , eCollection 2021. PMID:34955864^[1]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.